Central Drugs Standard Control Organisation (CDSCO): Current Affairs, GK & News - 2020-2021

Hetero’s injectable ‘Covifor’ gets DCGI approval for COVID-19 Treatment

Published: June 22, 2020

For the treatment of COVID-19 positive cases, on 21st June 2020, Hyderabad based pharmaceutical company -Hetero Drugs has received approval from the Drug Controller General of India (a department under- CDSCO: Central Drugs Standard Control Organization) for manufacturing and marketing of antiviral drug Remdesivir. Brandname for Marketing Under the brand name ‘Covifor’, Hetero Pharmaceuticals’ generic ..

Month: 

Category: 

Topics: 

India’s First Oral Vaccine for Moderate COVID-19 Cases gets Approval

Published: June 21, 2020

For the treatment of mild to moderate COVID-19 positive patients across the country, on 19th June 2020, for manufacturing and marketing of oral antiviral drug ‘Favipiravir (Fabiflu)’ was approved by the National Regulatory Authority for Indian pharmaceuticals -Central Drugs Standard Control Organisation (CDSCO) to Mumbai based Glenmark Pharmaceuticals. The approval for the drug was given ..

Month: 

Category: 

Topics: 

Advertisement